339 related articles for article (PubMed ID: 17100994)
41. Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization.
Jönsson G; Naylor TL; Vallon-Christersson J; Staaf J; Huang J; Ward MR; Greshock JD; Luts L; Olsson H; Rahman N; Stratton M; Ringnér M; Borg A; Weber BL
Cancer Res; 2005 Sep; 65(17):7612-21. PubMed ID: 16140926
[TBL] [Abstract][Full Text] [Related]
42. Uptake of offer to receive genetic information about BRCA1 and BRCA2 mutations in an Australian population-based study.
Keogh LA; Southey MC; Maskiell J; Young MA; Gaff CL; Kirk J; Tucker KM; Rosenthal D; McCredie MR; Giles GG; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2258-63. PubMed ID: 15598789
[TBL] [Abstract][Full Text] [Related]
43. High frequency of somatic missense mutation of BRCA2 in female breast cancer from Taiwan.
Chen FM; Hou MF; Chang MY; Wang JY; Hsieh JS; Ou-Yang F; Huang TJ; Lin SR
Cancer Lett; 2005 Apr; 220(2):177-84. PubMed ID: 15766593
[TBL] [Abstract][Full Text] [Related]
44. BRCA1-2 mutations in breast cancer: identification of nine new variants of BRCA1-2 genes in a population from central Western Spain.
Salazar R; Cruz-Hernandez JJ; Sanchez-Valdivieso E; Rodriguez CA; Gomez-Bernal A; Barco E; Fonseca E; Portugal T; Gonzalez-Sarmiento R
Cancer Lett; 2006 Feb; 233(1):172-7. PubMed ID: 15876480
[TBL] [Abstract][Full Text] [Related]
45. BRCA-1 and BRCA-2 mutations as prognostic factors in clinical practice and genetic counselling.
Nicoletto MO; Donach M; De Nicolo A; Artioli G; Banna G; Monfardini S
Cancer Treat Rev; 2001 Oct; 27(5):295-304. PubMed ID: 11871866
[TBL] [Abstract][Full Text] [Related]
46. Founder mutation in the BRCA1 gene in Malay breast cancer patients from Singapore.
Lee AS; Ho GH; Oh PC; Balram C; Ooi LL; Lim DT; Wong CY; Hong GS
Hum Mutat; 2003 Aug; 22(2):178. PubMed ID: 12872263
[TBL] [Abstract][Full Text] [Related]
47. Mutation analysis of the breast cancer gene BRCA1 among breast cancer Jordanian females.
Atoum MF; Al-Kayed SA
Saudi Med J; 2004 Jan; 25(1):60-3. PubMed ID: 14758382
[TBL] [Abstract][Full Text] [Related]
48. Mutational analysis of BRCA2 in Spanish breast cancer patients from Castilla-Leon: identification of four novel truncating mutations.
Duran M; Esteban-Cardeñosa E; Velasco E; Infante M; Miner C
Hum Mutat; 2003 Apr; 21(4):448. PubMed ID: 12655567
[TBL] [Abstract][Full Text] [Related]
49. Oncogenic pathways in hereditary and sporadic breast cancer.
Kenemans P; Verstraeten RA; Verheijen RH
Maturitas; 2004 Sep; 49(1):34-43. PubMed ID: 15351094
[TBL] [Abstract][Full Text] [Related]
50. Japanese Late-Onset Breast Cancer Families: Their Clincopathological Characteristics and Absence of BRCA1 and BRCA2 Germline Mutations.
Okumura T; Fukutomi a; Tsuda H; Kanai Y; Ushijima T; Akashi-Tanaka S; Nanasawa T
Breast Cancer; 1998 Jul; 5(3):251-254. PubMed ID: 11091655
[TBL] [Abstract][Full Text] [Related]
51. TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors.
Sinclair CS; Adem C; Naderi A; Soderberg CL; Johnson M; Wu K; Wadum L; Couch VL; Sellers TA; Schaid D; Slezak J; Fredericksen Z; Ingle JN; Hartmann L; Jenkins RB; Couch FJ
Cancer Res; 2002 Jul; 62(13):3587-91. PubMed ID: 12097257
[TBL] [Abstract][Full Text] [Related]
52. A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genes.
Musolino A; Naldi N; Michiara M; Bella MA; Zanelli P; Bortesi B; Capelletti M; Savi M; Neri TM; Ardizzoni A
Breast Cancer Res Treat; 2005 May; 91(2):203-5. PubMed ID: 15868448
[TBL] [Abstract][Full Text] [Related]
53. The analysis of BRCA1 mutations in eastern Chinese patients with early onset breast cancer and affected relatives.
Hu Z; Wu J; Liu CH; Lu JS; Luo JM; Han QX; Shen ZZ; Shao ZM
Hum Mutat; 2003 Jul; 22(1):104. PubMed ID: 12815604
[TBL] [Abstract][Full Text] [Related]
54. Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers.
Palacios J; Honrado E; Osorio A; Cazorla A; Sarrió D; Barroso A; Rodríguez S; Cigudosa JC; Diez O; Alonso C; Lerma E; Dopazo J; Rivas C; Benítez J
Breast Cancer Res Treat; 2005 Mar; 90(1):5-14. PubMed ID: 15770521
[TBL] [Abstract][Full Text] [Related]
55. Mutations at BRCA1: the medullary breast carcinoma revisited.
Eisinger F; Jacquemier J; Charpin C; Stoppa-Lyonnet D; Bressac-de Paillerets B; Peyrat JP; Longy M; Guinebretière JM; Sauvan R; Noguchi T; Birnbaum D; Sobol H
Cancer Res; 1998 Apr; 58(8):1588-92. PubMed ID: 9563465
[TBL] [Abstract][Full Text] [Related]
56. BRCA2 mutations in 154 finnish male breast cancer patients.
Syrjäkoski K; Kuukasjärvi T; Waltering K; Haraldsson K; Auvinen A; Borg A; Kainu T; Kallioniemi OP; Koivisto PA
Neoplasia; 2004; 6(5):541-5. PubMed ID: 15548363
[TBL] [Abstract][Full Text] [Related]
57. Patients with an unclassified genetic variant in the BRCA1 or BRCA2 genes show different clinical features from those with a mutation.
Gómez-García EB; Ambergen T; Blok MJ; van den Wijngaard A
J Clin Oncol; 2005 Apr; 23(10):2185-90. PubMed ID: 15800311
[TBL] [Abstract][Full Text] [Related]
58. TP53 mutations in familial breast cancer: functional aspects.
Gasco M; Yulug IG; Crook T
Hum Mutat; 2003 Mar; 21(3):301-6. PubMed ID: 12619116
[TBL] [Abstract][Full Text] [Related]
59. Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas.
Aghmesheh M; Edwards L; Clarke CL; Byth K; Katzenellenbogen BS; Russell PJ; Friedlander M; Tucker KM; de Fazio A
Gynecol Oncol; 2005 Apr; 97(1):16-25. PubMed ID: 15790432
[TBL] [Abstract][Full Text] [Related]
60. Testing for BRCA1 mutations: a cost-effectiveness analysis.
Sevilla C; Moatti JP; Julian-Reynier C; Eisinger F; Stoppa-Lyonnet D; Bressac-de Paillerets B; Sobol H
Eur J Hum Genet; 2002 Oct; 10(10):599-606. PubMed ID: 12357330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
